In short
Hyperinsulinism is a complex disorder where the pancreas produces too much insulin, leading to dangerously low blood sugar levels that can threaten brain development and overall health, particularly in newborns and young children.
Key points
- Hyperinsulinism causes the pancreas to produce too much insulin, leading to dangerously low blood sugar that can cause permanent brain damage if not treated promptly.
- The condition affects about 1 in 25,000 to 50,000 newborns and is the most common cause of severe, persistent hypoglycemia in babies and young children.
- Mutations in at least 12 different genes can cause congenital hyperinsulinism, though in about half of all cases the genetic cause remains unknown.
- Unlike other causes of low blood sugar, hyperinsulinism prevents the body from producing ketones as backup brain fuel, making it uniquely dangerous for neurological development.
- Symptoms in infants are often subtle and easily confused with normal newborn behavior, including excessive sleepiness, poor feeding, irritability, and lethargy.
- Children with focal hyperinsulinism—where only a small part of the pancreas is affected—can often be completely cured through targeted surgery, while those with diffuse disease require long-term medical management.
- Maintaining blood sugar levels above 60 milligrams per deciliter at all times is critical to preventing brain injury and improving long-term outcomes.
- New technologies like continuous glucose monitoring systems and specialized PET scans have dramatically improved both the diagnosis and management of hyperinsulinism in recent years.
Understanding Hyperinsulinism
Hyperinsulinism represents a group of disorders characterized by excessive production of insulin from specialized cells in the pancreas called beta cells. Insulin is a crucial hormone that helps regulate blood sugar levels by moving glucose from the bloodstream into cells where it can be used for energy. When too much insulin is released, blood sugar drops to dangerous levels, a condition known as hypoglycemia.
The condition exists in different forms, with congenital hyperinsulinism being present from birth due to genetic changes, while other forms can develop later in life. During the neonatal and infant period, hyperinsulinemic hypoglycemia is the most common and severe cause of persistent low blood sugar. The brain requires a constant supply of glucose to function properly, and when insulin levels are too high, the brain becomes starved of this essential fuel.
What makes hyperinsulinism particularly dangerous is that insulin blocks the body's ability to create alternative fuels. Normally, when blood sugar drops, the body breaks down fats to produce substances called ketones, which can serve as emergency fuel for the brain. However, because insulin inhibits both fat breakdown and ketone production, children with hyperinsulinism face a double threat—not only is their blood sugar low, but their brain also lacks backup energy sources.
How Common Is Hyperinsulinism
Congenital hyperinsulinism is considered a rare disease, though it remains the most frequent cause of severe, persistent low blood sugar in babies. The condition affects approximately one in every 25,000 to 50,000 newborns worldwide, with both males and females equally affected.
In the United States, there are an estimated 80 to 120 new cases of hyperinsulinism diagnosed each year. Because the condition is so rare and complex, most children's hospitals encounter only one or two cases annually, which is why specialized treatment centers with experienced multidisciplinary teams are crucial for proper management.
The rarity of the condition means that many healthcare providers may not immediately recognize the symptoms, potentially leading to delays in diagnosis. This scarcity also contributes to the challenge of developing new treatments, as gathering sufficient data for research studies can be difficult.
What Causes Hyperinsulinism
The underlying causes of hyperinsulinism vary depending on the type. In congenital cases, the disorder stems from changes in genes that control how insulin is released from pancreatic beta cells. Scientists have identified mutations in 12 different genes that can lead to this condition, including genes known as ABCC8, KCNJ11, GLUD1, GCK, HADH, SLC16A1, UCP2, HNF4A, HNF1A, HK1, PGM1, and PMM2. However, in approximately 50 percent of cases, the genetic mechanism remains unknown, suggesting that additional disease-causing genes have yet to be discovered.
These genetic mutations cause problems with the normal mechanisms that regulate insulin secretion. Each of these genes normally plays an important role in causing beta cells to produce insulin when blood sugar is high and to stop production when blood sugar drops to normal or low levels. When mutations affect these genes, the cells lose their ability to properly sense blood sugar levels or respond appropriately, resulting in excessive and unregulated insulin release.
Congenital hyperinsulinism can be inherited from parents in different patterns. Some forms require mutations from both parents, while others need only one mutated gene from a single parent. In some cases, the genetic changes occur spontaneously and are not inherited from either parent.
Not all cases of hyperinsulinism are genetic. A temporary form known as transient hyperinsulinism can affect newborns due to stress during labor and immediately after birth. This can happen when there are problems with the placenta or when the baby doesn't get enough oxygen during delivery. Other factors that can trigger transient hyperinsulinism include prematurity, maternal diabetes during pregnancy (especially if poorly controlled), heart disease, and severe infections in the pregnant mother.
Additionally, hyperinsulinism can occur as part of other genetic syndromes, including Beckwith-Wiedemann syndrome, Kabuki syndrome, Sotos syndrome, and Turner syndrome. In rare cases, tumors of the pancreas called insulinomas can cause excessive insulin production, though this is distinctly different from congenital forms of the disease.
Risk Factors for Developing Hyperinsulinism
Several factors can increase the likelihood of a child being born with or developing hyperinsulinism. Genetic predisposition plays the most crucial role, especially in congenital forms. When certain genetic mutations that affect the function of pancreatic beta cells are present, they can lead to the disorder. Families with a history of hyperinsulinism have a higher risk of having affected children.
Consanguinity, or marriage between close blood relatives, increases the risk of recessive genetic forms of hyperinsulinism, where both parents must carry the mutated gene. This is because related individuals are more likely to carry the same genetic mutations.
For transient forms, babies born prematurely face elevated risk. Maternal health during pregnancy significantly impacts risk—poorly controlled diabetes in the mother can lead to temporary hyperinsulinism in the newborn. Complications during pregnancy such as preeclampsia, placenta problems, or situations where the baby experiences oxygen deprivation can also trigger the condition.
Certain medical procedures can also influence risk. Some individuals who undergo gastric bypass surgery may develop hyperinsulinism afterward. The theory suggests that changes in the digestive system following surgery cause the beta cells to become overly large and active for the body's needs.
Recognizing the Symptoms
Identifying hyperinsulinism can be challenging because symptoms of low blood sugar, particularly in infants and newborns, can be vague and easily confused with typical newborn behavior. This difficulty in recognition is one reason why prompt diagnosis is so critical—delays can lead to serious complications.
In newborns and infants, common signs include excessive hunger, even shortly after feeding. The baby may appear irritable without an obvious cause, or conversely, may seem unusually lethargic and difficult to rouse. Excessive sleepiness that goes beyond normal infant sleep patterns can be a warning sign. Some babies may have a rapid heart rate, appear pale, or in severe cases, develop a bluish discoloration around the mouth and face called cyanosis.
Feeding difficulties are frequently observed—the baby may have trouble latching, suck weakly, or refuse to eat despite clear hunger cues. These feeding problems can compound the underlying issue, as inadequate nutrition intake further contributes to low blood sugar levels.
As children grow older, symptoms may become somewhat easier to identify. Older children with hyperinsulinism might experience shaking or trembling, weakness, confusion, or difficulty concentrating. They may express intense feelings of hunger even after eating. Some children develop anxiety or experience unusual mood changes when their blood sugar drops.
The most serious symptoms occur when blood sugar remains very low for extended periods or drops to extremely dangerous levels. In these situations, children can experience seizures or fall into a coma. These severe episodes can cause permanent brain damage, potentially leading to developmental delays, motor disabilities, learning problems, cerebral palsy, and in rare cases, even death. Medical professionals generally consider blood sugar levels above 70 milligrams per deciliter to be normal, while anything below 60 milligrams per deciliter is considered low. Levels below 50 milligrams per deciliter are particularly dangerous and may cause serious symptoms requiring immediate medical intervention.
Understanding Different Types of Hyperinsulinism
Hyperinsulinism is not a single disease but rather encompasses several distinct types, each with different underlying causes and characteristics. Understanding these types helps guide treatment decisions and predict outcomes.
One major distinction involves whether the entire pancreas is affected or only a specific area. Diffuse hyperinsulinism means that all the beta cells throughout the pancreas are abnormal and producing too much insulin. In contrast, focal hyperinsulinism involves only a small, isolated area of abnormal tissue within the pancreas, while the rest of the organ functions normally. This distinction is clinically crucial because focal disease can often be cured completely by surgically removing just the affected area.
Several genetic types exist, each caused by mutations in different genes. The most common types involve problems with potassium channels in beta cells, known as KATP channels, which help control insulin release. When genes called ABCC8 or KCNJ11 are mutated, these channels don't work properly, causing uncontrolled insulin secretion. Some patients with these mutations respond to a medication called diazoxide, while others do not.
In GDH-HI, caused by mutations in the GLUD1 gene, excess insulin secretion occurs particularly when the child hasn't eaten for a while or when they consume protein. This form also causes higher levels of ammonia in the blood and, in some cases, may trigger seizures even when blood sugar is normal.
Glucokinase HI results from mutations affecting an enzyme that acts as a glucose sensor in beta cells. With this type, the cells cannot turn off insulin production when blood sugar runs low because they incorrectly perceive glucose levels as being higher than they actually are.
Some rare forms include MCT-1 HI, which can be triggered by exercise, and SCHAD-HI, caused by a rare disorder affecting how the body processes fatty acids. Forms called HNF1a and HNF4a defects are unusual because while they cause hyperinsulinism in infancy, they may progress to diabetes during adolescence or adulthood. UCP-2 HI is a rare type that typically resolves on its own over time.
Transient hyperinsulinism usually affects newborns and is associated with stressors during labor and immediately after birth. Unlike genetic forms, this type typically resolves after a few weeks to several months and does not require lifelong treatment.
How the Body's Normal Processes Go Wrong
To understand hyperinsulinism, it helps to know how insulin regulation normally works. Pancreatic beta cells are finely tuned to secrete insulin so that blood glucose levels remain within a narrow physiological range, typically between 3.5 and 5.5 millimoles per liter. These cells act like sophisticated glucose sensors, constantly monitoring blood sugar and releasing just the right amount of insulin to maintain balance.
In a healthy person, when blood sugar rises after eating, beta cells respond by releasing insulin. This insulin helps move glucose from the bloodstream into cells throughout the body. Conversely, when blood sugar drops between meals, beta cells stop releasing insulin, allowing glucose levels to be maintained through other mechanisms like breaking down stored glycogen in the liver or producing glucose from other sources.
In hyperinsulinism, this elegant regulatory system malfunctions. The beta cells lose their ability to properly sense glucose levels or to appropriately control insulin release. As a result, they continue pumping out insulin even when blood sugar is already low, driving glucose levels down even further. This inappropriate insulin secretion in the presence of low blood sugar defines hyperinsulinism.
The metabolic consequences extend beyond just low blood sugar. Insulin has several important effects on metabolism that compound the problem. It increases how quickly glucose is used by muscles and other tissues. It stimulates the liver to store glucose as glycogen and prevents the liver from breaking down glycogen back into glucose. Insulin also blocks the liver from making new glucose through a process called gluconeogenesis.
Additionally, insulin exerts powerful effects on fat metabolism. It stimulates the storage of fats and critically, it inhibits the breakdown of fats into free fatty acids and ketone bodies. Under normal circumstances of low blood sugar, the body would break down fats to produce ketones, which serve as alternative fuel for the brain. However, in hyperinsulinism, this protective mechanism is blocked, leaving the brain without any fuel source when glucose runs out.
The brain is particularly vulnerable to this fuel deprivation. Unlike other organs that can use fatty acids for energy, the brain relies almost exclusively on glucose, with ketones serving as the only alternative fuel. Infants and children have even greater glucose needs than adults—while adults require about 2 to 3 milligrams of glucose per kilogram of body weight per minute, infants and children need 5 to 7 milligrams per kilogram per minute. When both glucose and ketones are unavailable, brain cells begin to suffer damage within minutes.
Preventing Hyperinsulinism and Its Complications
For congenital forms of hyperinsulinism caused by genetic mutations, there is no known way to prevent the condition from occurring. However, genetic counseling can help families understand their risk of having affected children, particularly in families where the condition has occurred before or where parents are closely related.
For transient forms, managing maternal health during pregnancy may help reduce risk. Pregnant women with diabetes should work closely with their healthcare providers to maintain optimal blood sugar control throughout pregnancy. Proper prenatal care can help identify and manage complications like preeclampsia or placenta problems that might contribute to neonatal hyperinsulinism.
Once hyperinsulinism is diagnosed, prevention efforts focus on avoiding the serious complications of the condition, particularly brain damage from repeated or prolonged episodes of low blood sugar. Maintaining blood glucose levels above 60 milligrams per deciliter at all times is essential to reduce the possibility of neurological injury. Healthcare teams aim to keep levels above this threshold through a combination of frequent feeding, medications, and in some cases, surgical intervention.
Parents and caregivers must learn to recognize the early signs of low blood sugar and know how to respond appropriately. This includes monitoring blood sugar levels before each feeding and whenever symptoms appear. For children old enough to skip feedings, ensuring they can safely tolerate periods without eating—typically no more than six hours for infants—is an important safety measure.
New technologies, including continuous glucose monitoring systems, are making it easier to track blood sugar trends in a minimally invasive way. These devices can alert caregivers to dropping glucose levels before serious symptoms develop, allowing for preventive action. Such monitoring tools have significantly improved the ability to prevent hypoglycemic episodes and have contributed to better neurological outcomes for children with hyperinsulinism.
Education and support are critical components of prevention. Families need training on medication administration, blood sugar monitoring, emergency protocols, and nutritional management. Access to specialized centers with experienced teams is important, as these centers can provide comprehensive care and help families navigate the complexities of managing this rare condition. Only with proper awareness of the disease and available tools can medical teams effectively prevent brain injury and improve long-term outcomes for affected children.
